The #NoGoingBack pledge is a statement from organisations across the world to continue forging forward. It’s a united front, and shows the importance of clinical leaders coming together to continue the momentum we’ve created in improving clinical trial conduct around the world.

Decentralisation of clinical trials has been a growing topic of discussion and development over the last few years, enabled further by the advancement of available technologies. Here, we explore what we mean when we talk about decentralised trials and discuss why the clinical research industry has been reluctant to pursue this route. We illuminate the […]

We explore how to look beyond the most common challenges faced by study organisers, and identify whether a clinical trial is an appropriate candidate for either a fully decentralised or hybrid model.

Our webinar panel discussed the challenges with new clinical trial technologies and how to deploy technologies that can deliver greater patient insight and engagement to ultimately improve patients’ safety and their trial experience.

The clinical trial landscape has changed dramatically since the outbreak of COVID-19. For the clinical research industry, these past few months have been anything but business as usual. However, it hasn’t meant clinical trials can’t continue, and many in the industry have been working together to find a ‘new normal’.

Let’s take a look at some of the ways in which wearable sensors have changed the landscape of healthcare and clinical research.